Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Celltrion Inc
Watchlist
More Discussions on Impacts of Celltrion's KOSPI200 Inclusion
Event-Driven
591 Views
22 Aug 2017 20:03
Celltrion Inc (068270 KS) said in a regulatory filing that it will have EGM at 10 AM on Aug 29 to decide whether it will move to KOSPI. Below is...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 6-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Asia ECM
South Korea
Equity Bottom-Up
Sell / Short Ideas
Event-Driven
Asia Event-Driven
Japan
Philippines
Financials
Trending Insights
More »
[Quiddity Index] MV Junior Gold Miners Sep25 Rebalance Predictions: Flow Expectations
HSCI Index Rebalance Preview and Stock Connect (Sep 2025): Plenty of Recent IPOs Could Be Added
NTT DC REIT IPO: The Investment Case
Anjoy Foods Group A/H Trading - Cheap Price but Sluggish Demand
Ohayo Japan | Jobs Data Lifts Wall Street to Record Highs
Top Unpaywalled Insights
More »
Oversupply Meets Tepid Demand Weighing Down on Soybean Meal
[IO Technicals 2025/26] Bearish Momentum Intensifies
"The Data Bottleneck in Quant Finance — and How to Break It" With David Forino, CTO of Quanted
The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Celltrion (068270 KS): Korean Making Biological Drugs for the West
05 Jan 2018
Celltrion's KOSPI Move - Seo Jung-Jin, Temasek & Price Predictions
28 Sep 2017
Celltrion Has Potential Manufacturing Headaches
07 Sep 2017
NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move
10 Aug 2017
Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options
17 Jul 2017
Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics
13 Jul 2017
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.7
x